CVSA Share Price Performance
US$112.04
8.26 (7.96%)
26.9% undervalued intrinsic discount
US$153.25
Fair Value
Price US$112.04
AnalystConsensusTarget US$153.25
AnalystHighTarget US$175.00
Fair ValueUS$153.25
Share Pricen/a
Covista Inc. Stock Price
- 2 Narratives written by author
- 0 Comments on narratives written by author
- 27 Fair Values set on narratives written by author
CVSA Community Narratives
AN
Fair Value US$153.25 26.9% undervalued intrinsic discount
Health Care Workforce Shortages And Digital Learning Will Support This Bullish Long Term Thesis
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
Fair Value US$175 36.0% undervalued intrinsic discount
Health Care Workforce Shortages And Flexible Learning Will Support Stronger Long Term Outcomes
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
Health Care Workforce Shortages And Digital Learning Will Support This Bullish Long Term Thesis
Catalysts About Covista Covista provides higher education programs focused on health care and related professional fields. What are the underlying business or industry changes driving this perspective?Read more
2
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
US$153.25
26.9% undervalued intrinsic discount
Fair Value
Revenue
6.99% p.a.
Profit Margin
15.08%
Future PE
16.6x
Price in 2029
US$189.37
Health Care Workforce Shortages And Flexible Learning Will Support Stronger Long Term Outcomes
Catalysts About Covista Covista focuses on large scale health care education programs serving nursing, medical, veterinary and allied health students across the United States. What are the underlying business or industry changes driving this perspective?Read more
4
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
US$175
36.0% undervalued intrinsic discount
Fair Value
Revenue
7.45% p.a.
Profit Margin
16.24%
Future PE
17.43x
Price in 2029
US$216.88
Trending Discussion
Recently Updated Narratives
AN
Health Care Workforce Shortages And Digital Learning Will Support This Bullish Long Term Thesis
Fair Value: US$153.25 26.9% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Health Care Workforce Shortages And Flexible Learning Will Support Stronger Long Term Outcomes
Fair Value: US$175 36.0% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Covista Inc. Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
May 07, 2026
- 7.36
- 57.38%
- 13.45%
- 36.6%
About CVSA
- Founded
- 1987
- Employees
- 4727
- CEO
- WebsiteView website
Covista Inc., together with its subsidiaries, provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. It operates in three segments: Chamberlain, Walden, and Medical and Veterinary. The company offers degree and non-degree programs, including bachelor’s, master’s, and doctoral degrees; and online certificate programs for nursing, health professions, medical, and veterinary postsecondary education, counseling, business, information technology, psychology, public health, social work and human services, public administration and public policy, and criminal justice. It also operates Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. The company was formerly known as Adtalem Global Education Inc. and changed its name to Covista Inc. in February 2026. Covista Inc. was incorporated in 1987 and is headquartered in Chicago, Illinois.
